Diagnostics News and Research

RSS

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.

29 Jan 2011

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

XDx, a San Francisco-based molecular diagnostics company focused on non-invasive gene expression-based tests for the monitoring of organ transplant rejection and autoimmune diseases, announced today that it has established a $12.5 million senior secured multi-draw term loan facility with GE Capital, Healthcare Financial Services.

28 Jan 2011

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

IDEXX Laboratories, Inc., today reported that revenues for the fourth quarter of 2010 increased 5% to $283.8 million, from $270.3 million for the fourth quarter of 2009. Organic revenue growth, as defined below, was 6%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2010 increased 22% to $0.62, compared to $0.51 for the same period in the prior year.

28 Jan 2011

NIH awards CCTSI $2.2 million grant to advance personalized medicine

A federal grant totaling $2.2 million shows how the University of Colorado School of Medicine and Anschutz Medical Campus are using technology to advance the cutting-edge field of personalized medicine -- tailoring treatments to the individual based on their genetic make-up.

28 Jan 2011

Transcranial magnetic stimulation helps rats to learn more quickly

What sounds like science fiction is actually possible: thanks to magnetic stimulation, the activity of certain brain nerve cells can be deliberately influenced. What happens in the brain in this context has been unclear up to now. Medical experts from Bochum under the leadership of Prof. Dr. Klaus Funke (Department of Neurophysiology) have now shown that various stimulus patterns changed the activity of distinct neuronal cell types.

28 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

OHC responds positively to Ontario Medical Association pre-election recommendations

The Ontario Health Coalition is responding positively, overall, to the pre-election recommendations made by the Ontario Medical Association.

28 Jan 2011

Endo and Orion enter oncology R&D collaboration

Endo Pharmaceuticals announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology.

28 Jan 2011

Golden Helix releases new Sequence Analysis Module for SNP & Variation Suite

Golden Helix, Inc. today announced the release of a new Sequence Analysis Module for its SNP & Variation Suite software. The new module introduces innovative tertiary analysis methods for next-generation DNA sequencing studies.

27 Jan 2011

GE to establish Global Pathology Imaging Centre of Excellence in Ontario

GE announced an agreement to establish its first Global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Commercialization Program created by HTX and funded by the Ontario Ministry of Research and Innovation.

27 Jan 2011

TD2 and Flagship Biosciences offer combined oncology and pathology services

TGen Drug Development (TD2) and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.

27 Jan 2011

New Mexico implements software module to link telemedicine services to other systems

New Mexico Software, a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the company virtually unlimited ability to link its XR-EXpress telemedicine services to other systems.

27 Jan 2011

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

HTX announced today an agreement to establish GE's first global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE Healthcare and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Exchange (HTX). Planned collaborative research and development (R&D) partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

27 Jan 2011

QIAGEN announces formation of subsidiary in India

QIAGEN today announced the formation of its India subsidiary, QIAGEN India Pvt. Ltd., and the beginning of direct sales in the country. Until now, QIAGEN products have been sold in India through distributor partnerships.

From QIAGEN Manchester Limited 27 Jan 2011

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Abbott today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted that, for symptomatic and asymptomatic carotid artery disease patients at standard surgical risk, there is reasonable assurance that the benefits of the RX ACCULINK® Carotid Stent System outweigh its risks (Yes: 7, No: 3, Abstain: 1).

27 Jan 2011

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

Avantra® Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx™ BioChip Immunoassay.

27 Jan 2011

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.

27 Jan 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

Quest Diagnostics releases new data on oral fluid testing system

OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

From Quest Diagnostics 27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

Diagnostics News and Research

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

NIH awards CCTSI $2.2 million grant to advance personalized medicine

Transcranial magnetic stimulation helps rats to learn more quickly

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

OHC responds positively to Ontario Medical Association pre-election recommendations

Endo and Orion enter oncology R&D collaboration

Golden Helix releases new Sequence Analysis Module for SNP & Variation Suite

GE to establish Global Pathology Imaging Centre of Excellence in Ontario

TD2 and Flagship Biosciences offer combined oncology and pathology services

New Mexico implements software module to link telemedicine services to other systems

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

QIAGEN announces formation of subsidiary in India

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Quest Diagnostics releases new data on oral fluid testing system

Nexstim closes additional equity financing for approximately EUR 11.4 million

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News